10948 Federal Register / Vol. 74, No. 48 / Friday, March 13, 2009 / Notices 

There is no commercial test for anthrax. 

This assay could be used for testing 

soldiers for anthrax exposure. 

Characterization of the interaction 

between LF and MAPKK at the amino 

acid level may lead to the generation of 

inhibitors which may prove useful in 

treating anthrax. 

Inventors: Nicholas S. Duesbery (NCI), 

Craig Webb (NCI), Stephen H. Leppla 

(NIDCR), George F. Vande Woude (NCI). 

Patent Status: 

U.S. Patent 6,485,925 issued 26 Nov 

2002 (HHS Reference No. E–068–1998/ 

0–US–06). 

U.S. Patent 6,893,835 issued 17 May 

2005 (HHS Reference No. E–068–1998/ 

0–US–07). 

U.S. Patent 6,911,203 issued 28 Jun 

2005 (HHS Reference No. E–068–1998/ 

0–US–08). 

U.S. Patent 7,056,693 issued 06 Jun 

2006 (HHS Reference No. E–068–1998/ 

0–US–10). 

U.S. Patent 7,183,071 issued 27 Feb 

2007 (HHS Reference No. E–068–1998/ 

0–US–11). 

International rights available. 

Licensing Status: Available for 

licensing. 

Licensing Contact: Surekha Vathyam, 

Ph.D.; 301–435–4076; 

vathyams@mail.nih.gov. 

Dated: March 5, 2009. 

Richard U. Rodriguez, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E9–5418 Filed 3–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Orthopaedics and Skeletal Biology. 

Date: March 20, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Daniel F. McDonald, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4110, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1215, mcdonald@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Ligament/ 

Tendon Repair and Replacement. 

Date: March 26, 2009. 

Time: 10 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: John P. Holden, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4211, 

MSC 7814, Bethesda, MD 20892, 301–496– 

8551, holdenjo@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Review of 

HIV/AIDS Related SBIR/STTR Applications. 

Date: April 1, 2009. 

Time: 10 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mark P. Rubert, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1775, rubertm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, BMIT/MEDI 

Member Conflict—Imaging. 

Date: April 2, 2009. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Dharam S. Dhindsa, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5110, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

1174, dhindsad@csr.nih.gov. 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.306, 

Comparative Medicine; 93.333, Clinical 

Research, 93.306, 93.333, 93.337, 

93.393–93.396, 93.837–93.844, 93.846– 

93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 4, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–5139 Filed 3–12–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

February 26, 2009, 8 a.m. to February 

28, 2009, 5 p.m., National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD, 20892 which was published in the 

Federal Register on February 6, 2009, 

74 FR 6292–6294. 

The meeting will be held March 25, 

2009 to March 27, 2009. The meeting 

time and location remain the same. The 

meeting is closed to the public. 

Dated: March 5, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–5344 Filed 3–12–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


sroberts on PROD1PC70 with NOTICES